Hong Seng Consolidated

Equities

HONGSENG

MYQ0041OO002

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
0.01 ^MYR	0.00%		-33.33%	-60.00%

May. 07	Malaysian Shares Extend Gains on Positive Cues; Proton's Vehicle Sales Rise 17% in April	MT
Apr. 19	Malaysian Shares Maintain Winning Streak; Key Alliance Group's Shares Balloon 100%	MT

Hong Seng Consolidated Berhad Announces Re-Designation of Yap Kien Ming from Chairman of Remuneration Committee to Member of Remuneration Committee

September 01, 2022 at 05:35 am EDT

Hong Seng Consolidated Berhad announced the re-designation of Mr. Yap Kien Ming, age 57 from Chairman of Remuneration Committee to Member of Remuneration Committee, effective September 1, 2022. Composition of Remuneration Committee: (1) Tuan Ng Keok Chai (Chairman) - Independent Non-Executive Director, (2) Yap Kien Ming (Member) - Independent Non-Executive Director, and (3) Leong Kam Soon (Member) - Independent Non-Executive Director.

Latest news about Hong Seng Consolidated

Malaysian Shares Extend Gains on Positive Cues; Proton's Vehicle Sales Rise 17% in April	May. 07	MT
Malaysian Shares Maintain Winning Streak; Key Alliance Group's Shares Balloon 100%	Apr. 19	MT
Hong Seng Consolidated Berhad Announces the Appointment of Mr. Leong Seng Wui as Executive Director	Apr. 08	CI
Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary	Mar. 01	CI
Hong Seng Consolidated Berhad Announces the Appointment of Lee Xiang Yee as Joint Secretary	Mar. 01	CI
Hong Seng Consolidated Berhad Reports Earnings Results for the Third Quarter Ended December 31, 2023	Feb. 27	CI
Hong Seng Consolidated Berhad Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 29	CI
Hong Seng Consolidated Berhad Reports Earnings Results for the Second Quarter Ended September 30, 2023	Nov. 29	CI
Hong Seng Consolidated Berhad(KLSE:HONGSENG) dropped from S&P Global BMI Index	23-09-18	CI
Hong Seng Consolidated Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-29	CI
Hong Seng Consolidated Changes Financial Year End	23-07-24	MT
Hong Seng Consolidated Berhad Announces Change in Financial Year End	23-07-21	CI
Hong Seng Acquires 32.61% of Total Issued Shares of Classita	23-07-17	MT
Hong Seng Consolidated Berhad acquired a 32.61% stake in Classita Holdings Berhad	23-07-13	CI
Hong Seng Consolidated Berhad Announces Resignation of Dato' Seri Teoh Hai Hin as Group Managing Director	23-07-10	CI
Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director	23-07-10	CI
Hong Seng Consolidated Berhad Announces Update on Memorandum of Understanding with EoCell Inc	23-06-09	CI
Hong Seng Consolidated Berhad Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-25	CI
Hong Seng Consolidated to Sell 51% Stake in Innov8tif for MYR36 Million	23-05-15	MT
Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary	23-05-10	CI
Hong Seng Consolidated Berhad Announces Resignation of Dato' Mohamed Suffian Bin Awang as Independent and Non Executive Non Executive Chairman	23-04-28	CI
Hong Seng Consolidated Berhad cancelled the acquisition of Alliance EV Sdn Bhd from CSH Alliance Berhad.	23-04-12	CI
Hong Seng Consolidated Unit Wins Regulatory Nod for Managed Care Business Venture	23-04-11	MT
Hong Seng Consolidated Berhad Announces Cessation of Office of Tuan Ng Keok Chai as Independent and Non Executive Chairman of Remuneration Committee	23-03-21	CI
Hong Seng Consolidated Berhad Announces Re-designation of Yap Kien Ming as Independent and Non Executive Chairman of Remuneration Committee	23-03-21	CI

Chart Hong Seng Consolidated

Duration

Period

More charts

Company Profile

Hong Seng Consolidated Berhad is a Malaysia-based investment holding company. The Company operates through four segments: Healthcare, Financial services, Gloves and Others. The Healthcare segment includes marketplace, medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods. The Financial services segment includes moneylending activities. The Gloves segment is engaged in the manufacturing and trading of rubber gloves. The Others segment is engaged in the investment holding, development and provision of software solutions/applications, training and seminars and other dormant companies. The Company through its subsidiaries engaged in the business of healthcare, financial services, and glove manufacturing amongst others mainly through the provisioning of a digital healthcare platform; diagnostics and health screening laboratory services; healthcare logistics solutions; moneylending facilities, and nitrile glove manufacturing and trading.

Sector

Healthcare Facilities & Services

Calendar

2024-05-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HONG SENG CONSOLIDATED	-60.00%	10.86M
HCA HEALTHCARE, INC.	+19.22%	85.64B
CVS HEALTH CORPORATION	-27.14%	70.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.05B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.23%	17.97B
FRESENIUS SE & CO. KGAA	+1.60%	17.58B
QUEST DIAGNOSTICS INCORPORATED	+3.30%	15.64B
REDE D'OR SÃO LUIZ S.A.	+7.13%	13.55B
FRESENIUS MEDICAL CARE AG	+9.91%	13.41B
NATERA, INC.	+73.32%	13.18B

Other Healthcare Facilities & Services